CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Republic of China (Taiwan)

NEW YORK, July 1, 2014 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Republic of China (Taiwan)

http://www.reportlinker.com/p02154166/CountryFocus-Healthcare-Regulatory-and-Reimbursement-Landscape---Republic-of-China-Taiwan.html

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Republic of China (Taiwan)

Summary

GlobalData, the industry analysis specialist, has released its latest report, "CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Republic of China (Taiwan)". The report is an essential source of information and analysis on the healthcare, regulatory and reimbursement landscape in the Republic of China (Taiwan). It identifies the key trends in the country's healthcare market and provides insights into its demographic, regulatory, and reimbursement landscape and healthcare infrastructure. Most importantly, the report provides valuable insights into the trends and segmentation of its pharmaceutical and medical device markets. It is built using data and information sourced from proprietary databases, secondary research, and in-house analysis by GlobalData's team of industry experts.

The population of Taiwan increased slightly between 2008 and 2013 from 23.0 to 23.4 million, mainly due to rising life expectancy. However, the birth rate decreased at a negative Compound Annual Growth Rate (CAGR) of 0.04% between 2008 and 2013. Government incentives such as those for new pharmaceutical companies establishing themselves in Taiwan, which include a reduction in income tax, will encourage foreign companies to invest. The country's pharmaceutical market was estimated at $5.7 billion in 2013 and is projected to reach $8.2 billion by 2020 at a CAGR of 5.2%. The medical device market was worth $2.2 billion in 2013 and is projected to reach $3.1 billion by 2020 at a CAGR of 5.0%. These positive growth trends can primarily be attributed to -
- An increasing elderly population
- Universal health coverage
- Government initiatives

Scope

The report provides information on the healthcare, regulatory, and reimbursement landscape in Taiwan, and includes -
- An overview of the pharmaceutical and medical device markets, comprising market size, segmentation, and key drivers and barriers
- Profiles and SWOT analyses of the major players in the pharmaceutical market: Pfizer, Sanofi-aventis, GlaxoSmithKline, Yung Shin Pharmaceutical and China Chemical & Pharmaceutical
- Insightful review of the reimbursement and regulatory landscape, with analysis covering details of the country's healthcare reimbursement process, regulatory agencies and the approval processes for new drugs and medical devices
- Detailed analysis of the political and economic environment, covering economic indicators, demographics, healthcare infrastructure and healthcare expenditure
- An overview of the opportunities for and challenges to growth in the Taiwanese healthcare market

Reasons to buy

This report will enhance your decision-making capability by allowing you to -
- Develop business strategies by understanding the trends shaping and driving Taiwan's healthcare market
- Drive revenues by understanding the key trends, reimbursement and regulatory policies, pharmaceutical market segments, and companies likely to affect Taiwan's healthcare market in the future
- Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing the performance of various competitors
- Organize your sales and marketing efforts by identifying the market categories and segments that present the best opportunities for consolidation, investment, and strategic partnership
- Identify, understand, and capitalize on the opportunities and challenges in Taiwan's healthcare market
1 Table of Contents
2 Introduction 20
2.1 GlobalData Report Guidance 20
3 Overview of the Pharmaceutical and Medical Device Markets 21
3.1 Pharmaceutical Market 21
3.1.1 Market Overview 21
3.1.2 Pharmaceutical Exports and Imports 23
3.1.3 Supply Channels 25
3.1.4 Market Segments 25
3.1.5 Overview of Top Five Disease Areas 29
3.1.6 Major Players 31
3.2 Medical Device Market 68
3.2.1 Market Overview 68
3.2.2 Overview of Top Five Segments 70
3.2.3 Diagnostic market 83
3.2.4 Major Players 86
3.3 Market Drivers and Barriers 116
3.3.1 Drivers 116
3.3.2 Barriers 117
4 Market Access 119
4.1 Reimbursement and Payer Landscape 119
4.1.1 Overview of Healthcare System 119
4.1.2 Reimbursement Process 121
4.1.3 Overview of Insurance Providers 124
4.1.4 Patient Share in Healthcare Spending 129
4.1.5 Price Trend in Healthcare Services 131
4.1.6 Pricing Policies 132
4.2 Regulatory Landscape 133
4.2.1 Overview of Regulatory Agencies 133
4.2.2 Market Authorization Procedure for Pharmaceutical Products 135
4.2.3 Market Authorization Procedure for Medical Devices 140
4.2.4 Licensing Process for Pharmaceutical and Medical Device Manufacturing 143
4.2.5 Licensing Process for Pharmaceutical Exports and Imports 146
4.2.6 Intellectual Property Rights 147
4.2.7 Clinical Trial Regulations 150
4.2.8 Pharmaceutical Advertising Regulations 152
4.2.9 Pharmacy Regulations 153
4.2.10 Labeling and Packaging Regulations 154
5 Country Analysis 155
5.1 Political Environment 155
5.1.1 Political Structure 155
5.1.2 Analysis of the Current Political Environment 156
5.1.3 Healthcare Policy Initiatives 157
5.2 Economic Landscape 158
5.3 Economic Indicators 160
5.3.1 Gross Domestic Product 160
5.3.2 National Income per Capita 164
5.3.3 Inflation 165
5.3.4 Currency Exchange Rate 169
5.3.5 Foreign Direct Investment 171
5.3.6 Foreign Exchange Reserves 173
5.3.7 Trade Balance 174
5.3.8 Government Structural Balance 177
5.3.9 General Government Gross Debt 179
5.3.10 Major Industries 181
5.4 Demographics 183
5.4.1 Population 183
5.4.2 Education and Literacy 200
5.4.3 Employment 202
5.4.4 Disease Burden 204
5.5 Healthcare Infrastructure 206
5.5.1 Healthcare Facilities 206
5.5.2 Healthcare Parameters 217
5.5.3 Environmental Health 219
5.5.4 Healthcare Personnel 224
5.6 Healthcare Expenditure 228
5.6.1 Overview 228
5.6.2 Major Components of Healthcare Spending 229
5.6.3 Public and Private Sector Share 231
5.6.4 Spending in Pharmaceutical R&D 233
5.7 Trade Associations 234
5.7.1 Taiwan Medical and Biotech Industry Association 234
5.7.2 Taiwan Public Health Association 234
5.7.3 Taiwan Medical Association 234
5.7.4 Taiwan Generic Pharmaceutical Association 234
5.8 Trade Fairs 235
6 Opportunities and Challenges 236
6.1 Opportunities 236
6.2 Challenges 237
7 Appendix 239
7.1 Abbreviations 239
7.2 Bibliography 244
7.3 Research Methodology 259
7.3.1 Coverage 259
7.3.2 Secondary Research 260
7.3.3 Forecasts 260
7.3.4 Expert Panel 260
7.4 Disclaimer 261


1.1
List of Tables


Table 1: Pharmaceutical Market, Republic of China (Taiwan), Revenue ($bn), 2008-2013 21
Table 2: Pharmaceutical Market, Republic of China (Taiwan), Revenue Forecast ($bn), 2014-2020 22
Table 3: Pharmaceutical Market, Republic of China (Taiwan), Population, Exports and Imports ($m), 2008-2013 23
Table 4: Pharmaceutical Device Market, Republic of China (Taiwan), Market Segments of Newly Emerging Biotech Industry, Share (%), 2009 27
Table 5: Pharmaceutical Device Market, Republic of China (Taiwan), Top Five Therapeutic Areas, Total Expenditure on Personal Health Care, 2012 28
Table 6: Pfizer, Global, Major Products, Revenue ($bn) and Annual Growth (%), 2013 31
Table 7: Pharmaceutical Market, Global, Late-Stage Pipeline, Pfizer, 2014 32
Table 8: Sanofi, Global, Major Products, Revenue ($bn) and Annual Growth (%), 2013 40
Table 9: Sanofi, Global, Late-Stage Pipeline, 2013 41
Table 10: GlaxoSmithKline, Global, Major Products, Revenue ($bn) and Annual Growth (%), 2013 49
Table 11: Pharmaceutical Market, Global, Late-Stage Pipeline, GlaxoSmithKline, 2014 50
Table 12: Major Products, China Chemical & Pharmaceutical, 2013 62
Table 13: Medical Device Market, Republic of China (Taiwan), Revenue ($bn), 2008-2013 68
Table 14: Medical Device Market, Republic of China (Taiwan), Revenue Forecast ($bn), 2014-2020 69
Table 15: Medical Device Market, Republic of China (Taiwan), Nephrology and Urology Devices Market ($m), 2008-2013 71
Table 16: Medical Device Market, Republic of China (Taiwan), Nephrology and Urology Devices Market, Sales Trend for Major Players, 2012 72
Table 17: Medical Device Market, Republic of China (Taiwan), Ophthalmic Devices Market ($m), 2008-2013 73
Table 18: Medical Device Market, Republic of China (Taiwan), Ophthalmic Devices Market, Sales Trend for Major Players, 2012 74
Table 19: Medical Device Market, Republic of China (Taiwan), In Vitro Diagnostics Device Market ($m), 2008-2013 76
Table 20: Medical Device Market, Republic of China (Taiwan), In Vitro Diagnostics Device Market, Sales Trend for Major Players, 2012 77
Table 21: Medical Device Market, Republic of China (Taiwan), Cardiovascular Devices Market ($m), 2008-2013 78
Table 22: Medical Device Market, Republic of China (Taiwan), Cardiovascular Devices Market, Sales Trend for Major Players, 2012 79
Table 23: Medical Device Market, Republic of China (Taiwan), Orthopedic Device Market, Revenue ($m), 2008-2013 81
Table 24: Medical Device Market, Republic of China (Taiwan), Orthopedic Device Market, Sales Trend for Major Players, 2012 82
Table 25: Medical Device Market, Republic of China (Taiwan), Diagnostic Market, Revenue ($bn), 2008-2013 83
Table 26: Medical Device Market, Republic of China (Taiwan), Diagnostic Market, Revenue Forecast ($bn), 2014-2020 84
Table 27: Major Products, Baxter International, Global, Revenue ($m) and Annual Growth (%), 2013 86
Table 28: Major Products, Fresenius Medical Care, 2013 92
Table 29: Medtronic, Global, Major Products Classes, 2014 109
Table 30: Healthcare System, Republic of China (Taiwan), NHI Premium Formulas, 2014 126
Table 31: Healthcare System, Republic of China (Taiwan), Basic Outpatient Care Co-payments, 2014 127
Table 32: Healthcare System, Republic of China (Taiwan), Basic Outpatient Care Co-payments, 2014 128
Table 33: Healthcare Spending, Republic of China (Taiwan), Out-of-Pocket Expenditure as Share of Total Healthcare Expenditure (%), 2008-2013 129
Table 34: Price of Prescription Drugs, Republic of China (Taiwan), Medical Care Services Price Trend (%), 2008-2013 131
Table 35: Healthcare System, Republic of China (Taiwan), Registration Fee Structure for New Drug Application ($), 2012 138
Table 36: Healthcare System, Republic of China (Taiwan), Regulatory Requirements for Medical Devices, 2013 139
Table 37: Market Access, Republic of China (Taiwan), Trademark Fees ($), 2014 147
Table 38: Market Access, Republic of China (Taiwan), Trademark Fees, 2012 149
Table 39: Economic Indicators, Republic of China (Taiwan), Gross Domestic Product per Capita ($), 2008-2013 160
Table 40: Economic Indicators, Republic of China (Taiwan), Gross Domestic Product per Capita Forecast ($), 2014-2020 160
Table 41: Economic Indicators, Republic of China (Taiwan), Gross Domestic Product Annual Growth (%), 2008-2013 162
Table 42: Economic Indicators, Republic of China (Taiwan), Gross Domestic Product Annual Growth Forecast (%), 2014-2020 163
Table 43: Economic Indicators, Republic of China (Taiwan), National Income per Capita ($), 2008-2013 164
Table 44: Economic Indicators, Republic of China (Taiwan), Average Consumer Price Index, 2008-2013 165
Table 45: Economic Indicators, Republic of China (Taiwan), Average Consumer Price Index Forecast, 2014-2020 166
Table 46: Economic Indicators, Republic of China (Taiwan), Average Consumer Price Annual Change (%), 2008-2013 168
Table 47: Economic Indicators, Republic of China (Taiwan), Currency Exchange Rate (TWD/$), 2008-2013 169
Table 48: Economic Indicators, Republic of China (Taiwan), Foreign Direct Investment ($bn), 2008-2013 171
Table 49: Economic Indicators, Republic of China (Taiwan), Foreign Exchange Reserves ($bn), 2008-2013 173
Table 50: Economic Indicators, Republic of China (Taiwan), Imports of Goods and Services ($bn), 2008-2013 174
Table 51: Economic Indicators, Republic of China (Taiwan), Exports of Goods and Services ($bn), 2008-2013 176
Table 52: Economic Indicators, Republic of China (Taiwan), Government Structural Balance ($bn), 2008-2013 177
Table 53: Economic Indicators, Republic of China (Taiwan), General Government Gross Debt (% of GDP), 2008-2013 178
Table 54: Economic Indicators, Republic of China (Taiwan), General Government Gross Debt Forecast (% of GDP), 2014-2020 179
Table 55: Economic Indicators, Republic of China (Taiwan), Major Industries, Gross Domestic Product by Industry ($bn), 2012 181
Table 56: Demographics, Republic of China (Taiwan), Population (million), 2008-2013 183
Table 57: Demographics, Republic of China (Taiwan), Population Forecast (million), 2014-2020 184
Table 58: Demographics, Republic of China (Taiwan), Urban-Rural Population (%), 2008-2013 185
Table 59: Demographics, Republic of China (Taiwan), Population Distribution by Age Group (%), 2008-2013 187
Table 60: Demographics, Republic of China (Taiwan), Population Distribution by Age Group Forecast (%), 2014-2020 187
Table 61: Demographics, Republic of China (Taiwan), Births (per 1,000 Population), 2008-2013 189
Table 62: Demographics, Republic of China (Taiwan), Mortality (per 1,000 Population), 2008-2013 190
Table 63: Demographics, Republic of China (Taiwan), Major Causes of Mortality (per 100,000 Population), 2012 192
Table 64: Demographics, Republic of China (Taiwan), Children
<5 Years Age, Infant Mortality Rate (per 1,000 Live Births), 2008-2013 194>Table 65: Demographics, Republic of China (Taiwan), Immunization Rate (%), 2012 195
Table 66: Demographics, Republic of China (Taiwan), Gender Ratio (M/F), 2008-2013 197
Table 67: Demographics, Republic of China (Taiwan), Life Expectancy at Birth (Years), 2008-2013 199
Table 68: Demographics, Republic of China (Taiwan), Student Net Enrollment by Level of Education (%), 2013 201
Table 69: Demographics, Republic of China (Taiwan), Unemployment Rate (%), 2008-2013 202
Table 70: Demographics, Republic of China (Taiwan), Employment by Sector (%), 2012 203
Table 71: Demographics, Republic of China (Taiwan), Personal Health Expenditure by Disease (%), 2012 204
Table 72: Demographics, Republic of China (Taiwan), Male Personal Health Expenditure per Capita by Disease ($), 2012 204
Table 73: Demographics, Republic of China (Taiwan), Female Personal Health Expenditure per Capita by Diseases ($), 2012 205
Table 74: Healthcare Infrastructure, Republic of China (Taiwan), Hospitals, 2008-2013 206
Table 75: Healthcare Infrastructure, Republic of China (Taiwan), Public and Private Hospitals, 2008-2013 208
Table 76: Healthcare Infrastructure, Republic of China (Taiwan), Public Hospitals, Share by Ownership and Number of Facilities, 2012 208
Table 77: Healthcare Infrastructure, Republic of China (Taiwan), Private Hospitals, Share by Ownership and Number of Facilities, 2012 209
Table 78: Healthcare Infrastructure, Republic of China (Taiwan), Hospitals by Standard of Care, Contracted by NHIA, 2008-2013 210
Table 79: Healthcare Infrastructure, Republic of China (Taiwan), Hospitals by Services Rendered, 2012 211
Table 80: Healthcare Infrastructure, Republic of China (Taiwan), Beds by Type of Hospital, 2008-2013 213
Table 81: Healthcare Infrastructure, Republic of China (Taiwan), Beds by Specialty, 2012 214
Table 82: Healthcare Infrastructure, Republic of China (Taiwan), Diagnostic Units, 2008-2013 215
Table 83: Healthcare Infrastructure, Republic of China (Taiwan), Hospital Beds (per 1,000 Population), 2008-2013 217
Table 84: Healthcare Infrastructure, Republic of China (Taiwan), Doctors (per 1,000 Population), 2008-2013 218
Table 85: Healthcare Infrastructure, Republic of China (Taiwan), PM10 (µg/m3), 2008-2013 220
Table 86: Healthcare Infrastructure, Republic of China (Taiwan), CO2 Emissions (million tons), 2008-2013 222
Table 87: Healthcare Infrastructure, Republic of China (Taiwan), Nurses (per 1,000 Population), 2008-2013 224
Table 88: Healthcare Infrastructure, Republic of China (Taiwan), Pharmacists (per 1,000 Population), 2008-2013 225
Table 89: Healthcare Infrastructure, Republic of China (Taiwan), Dentists (per 1,000 Population), 2008-2013 226
Table 90: Healthcare Expenditure, Republic of China (Taiwan), Healthcare Expenditure (% of GDP), 2008-2013 228
Table 91: Healthcare Expenditure, Republic of China (Taiwan), Primary Healthcare Expenditure, Current Health Expenditure by Provider (%), 2011 229
Table 92: Healthcare Expenditure, Republic of China (Taiwan), Primary Healthcare Expenditure, Current Health Expenditure by Mode of Production (%), 2011 230
Table 93: Healthcare Expenditure, Republic of China (Taiwan), Healthcare Expenditure, Public-Private Share (%), 2008-2013 231
Table 94: Healthcare Expenditure, Republic of China (Taiwan), Pharmaceutical R&D Expenditure, 2008-2013 232
Table 95: Healthcare Expenditure, Republic of China (Taiwan), Major Healthcare Trade Fairs, 2014 234


1.2 List of Figures

Figure 1: Pharmaceutical Market, Republic of China (Taiwan), Revenue ($bn), 2008-2013 22
Figure 2: Pharmaceutical Market, Republic of China (Taiwan), Revenue Forecast ($bn), 2014-2020 23
Figure 3: Pharmaceutical Market, Republic of China (Taiwan), Population, Exports and Imports ($m), 2008-2013 24
Figure 4: Pharmaceutical Market, Republic of China (Taiwan), Market Segments of Newly Emerging Biotech Industry, Share (%), 2009 28
Figure 5: Medical Device Market, Republic of China (Taiwan), Revenue ($bn), 2008-2013 69
Figure 6: Medical Device Market, Republic of China (Taiwan), Revenue Forecast ($bn), 2014-2020 70
Figure 7: Medical Device Market, Republic of China (Taiwan), Nephrology and Urology Devices Market ($m), 2008-2013 71
Figure 8: Medical Device Market, Republic of China (Taiwan), Nephrology and Urology Devices Market, Sales Trend for Major Players, Revenue* ($m), 2008-2012 72
Figure 9: Medical Device Market, Republic of China (Taiwan), Ophthalmic Devices Market ($m), 2008-2013 74
Figure 10: Medical Device Market, Republic of China (Taiwan), Ophthalmic Devices Market, Sales Trend for Major Players, Revenue ($m), 2008-2012 75
Figure 11: Medical Device Market, Republic of China (Taiwan), In Vitro Diagnostics Device Market ($m), 2008-2013 76
Figure 12: Medical Device Market, Republic of China (Taiwan), In Vitro Diagnostics Device Market, Sales Trend for Major Players, Revenue ($m), 2008-2012 77
Figure 13: Medical Device Market, Republic of China (Taiwan), Cardiovascular Devices Market ($m), 2008-2013 79
Figure 14: Medical Device Market, Republic of China (Taiwan), Cardiovascular Devices Market, Sales Trend for Major Players, Revenue ($m), 2008-2012 80
Figure 15: Medical Device Market, Republic of China (Taiwan), Orthopedic Device Market, Revenue ($m), 2008-2013 81
Figure 16: Medical Device Market, Republic of China (Taiwan), Orthopedic Device Market, Sales Trend for Major Players, Revenue ($m), 2008-2012 82
Figure 17: Medical Device Market, Republic of China (Taiwan), Diagnostic Market, Revenue ($bn), 2008-2013 84
Figure 18: Medical Device Market, Republic of China (Taiwan), Diagnostic Market, Revenue Forecast ($bn), 2014-2020 85
Figure 19: Healthcare Market, Republic of China (Taiwan), Drivers and Barriers, 2013 118
Figure 20: Healthcare System, Republic of China (Taiwan), Financial Flow in the Healthcare System, 2013 120
Figure 21: Healthcare System, Republic of China (Taiwan), Evolution of the Healthcare System, 1950-2013 121
Figure 22: Healthcare System, Republic of China (Taiwan), Reimbursement Process, 2008 123
Figure 23: Market Access, Republic of China (Taiwan), Process for Coverage and Reimbursement of Medical Devices, 2014 124
Figure 24: Healthcare System, Republic of China (Taiwan), Premium Collection under Second-Generation NHI System, 2014 127
Figure 25: Healthcare Spending, Republic of China (Taiwan), Out-of-Pocket Expenditure as Share of Total Healthcare Expenditure (%), 2008-2013 130
Figure 26: Price of Prescription Drugs, Republic of China (Taiwan), Medical Care Services Price Trend (%), 2008-2013 132
Figure 27: Market Access, Republic of China (Taiwan), Organization Structure of CDE, 2014 135
Figure 28: Market Access, Republic of China (Taiwan), Marketing Authorization Procedure for New Drugs, 2014 137
Figure 29: Market Access, Republic of China (Taiwan), New Drug Evaluation Process, 2013 138
Figure 30: Market Access, Republic of China (Taiwan), HTA Process for New Drug Listing Application with the NHIA, 2013 139
Figure 31: Market Access, Republic of China (Taiwan), Marketing Authorization Procedure for Medical Devices, 2013 143
Figure 32: Market Access, Republic of China (Taiwan), Clinical Trial Regulation Process for an IND, 2013 152
Figure 33: Economic Indicators, Republic of China (Taiwan), Gross Domestic Product per Capita ($), 2008-2013 160
Figure 34: Economic Indicators, Republic of China (Taiwan), Gross Domestic Product per Capita Forecast ($), 2014-2020 161
Figure 35: Economic Indicators, Republic of China (Taiwan), Gross Domestic Product Annual Growth (%), 2008-2013 162
Figure 36: Economic Indicators, Republic of China (Taiwan), Gross Domestic Product Annual Growth Forecast (%), 2014-2020 163
Figure 37: Economic Indicators, Republic of China (Taiwan), National Income per Capita ($), 2008-2013 164
Figure 38: Economic Indicators, Republic of China (Taiwan), Average Consumer Price Index, 2008-2013 166
Figure 39: Economic Indicators, Republic of China (Taiwan), Average Consumer Price Index Forecast, 2014-2020 167
Figure 40: Economic Indicators, Republic of China (Taiwan), Average Consumer Price Annual Change (%), 2008-2013 168
Figure 41: Economic Indicators, Republic of China (Taiwan), Currency Exchange Rate (TWD/$), 2008-2013 170
Figure 42: Economic Indicators, Republic of China (Taiwan), Foreign Direct Investment ($bn), 2008-2013 172
Figure 43: Economic Indicators, Republic of China (Taiwan), Foreign Exchange Reserves ($bn), 2008-2013 173
Figure 44: Economic Indicators, Republic of China (Taiwan), Imports of Goods and Services ($bn), 2008-2013 175
Figure 45: Economic Indicators, Republic of China (Taiwan), Exports of Goods and Services ($bn), 2008-2013 176
Figure 46: Economic Indicators, Republic of China (Taiwan), Government Structural Balance ($bn), 2008-2013 178
Figure 47: Economic Indicators, Republic of China (Taiwan), General Government Gross Debt (% of GDP), 2008-2013 179
Figure 48: Economic Indicators, Republic of China (Taiwan), General Government Gross Debt Forecast (% of GDP), 2014-2020 180
Figure 49: Economic Indicators, Republic of China (Taiwan), Major Industries, Gross Domestic Product by Industry ($bn), 2012 182
Figure 50: Demographics, Republic of China (Taiwan), Population (million), 2008-2013 184
Figure 51: Demographics, Republic of China (Taiwan), Population Forecast (million), 2014-2020 185
Figure 52: Demographics, Republic of China (Taiwan), Urban-Rural Population (%), 2008-2013 186
Figure 53: Demographics, Republic of China (Taiwan), Population Distribution by Age Group (%), 2008-2013 187
Figure 54: Demographics, Republic of China (Taiwan), Population Distribution by Age Group Forecast (%), 2014-2020 188
Figure 55: Demographics, Republic of China (Taiwan), Births (per 1,000 Population), 2008-2013 190
Figure 56: Demographics, Republic of China (Taiwan), Mortality (per 1,000 Population), 2008-2013 191
Figure 57: Demographics, Republic of China (Taiwan), Major Causes of Mortality (per 100,000 Population), 2012 193
Figure 58: Demographics, Republic of China (Taiwan), Children
<5 Years Age, Infant Mortality Rate (per 1,000 Live Births), 2008-2013 194>Figure 59: Demographics, Republic of China (Taiwan), Immunization Rate (%), 2012 196
Figure 60: Demographics, Republic of China (Taiwan), Gender Ratio (M/F), 2008-2013 198
Figure 61: Demographics, Republic of China (Taiwan), Life Expectancy at Birth (Years), 2008-2013 199
Figure 62: Demographics, Republic of China (Taiwan), Student Net Enrollment by Level of Education (%), 2013 201
Figure 63: Demographics, Republic of China (Taiwan), Unemployment Rate (%), 2008-2013 203
Figure 64: Demographics, Republic of China (Taiwan), Personal Health Expenditure by Disease (%), 2012 204
Figure 65: Healthcare Infrastructure, Republic of China (Taiwan), Hospitals, 2008-2013 207
Figure 66: Healthcare Infrastructure, Republic of China (Taiwan), Public and Private Hospitals, 2008-2013 208
Figure 67: Healthcare Infrastructure, Republic of China (Taiwan), Public Hospitals, Share by Ownership (%), 2012 209
Figure 68: Healthcare Infrastructure, Republic of China (Taiwan), Private Hospitals, Share by Ownership (%), 2012 210
Figure 69: Healthcare Infrastructure, Republic of China (Taiwan), Hospitals by Standard of Care, Contracted by NHIA, 2008-2013 211
Figure 70: Healthcare Infrastructure, Republic of China (Taiwan), Hospitals by Services Rendered (%), 2012 212
Figure 71: Healthcare Infrastructure, Republic of China (Taiwan), Beds by Type of Hospital, 2008-2013 213
Figure 72: Healthcare Infrastructure, Republic of China (Taiwan), Beds by Specialty, 2012 214
Figure 73: Healthcare Infrastructure, Republic of China (Taiwan), Diagnostic Units, 2008-2013 216
Figure 74: Healthcare Infrastructure, Republic of China (Taiwan), Hospital Beds (per 1,000 Population), 2008-2013 217
Figure 75: Healthcare Infrastructure, Republic of China (Taiwan), Doctors (per 1,000 Population), 2008-2013 218
Figure 76: Healthcare Infrastructure, Republic of China (Taiwan), PM10 (µg/m3), 2008-2013 221
Figure 77: Healthcare Infrastructure, Republic of China (Taiwan), CO2 emissions (million tons), 2008-2013 223
Figure 78: Healthcare Infrastructure, Republic of China (Taiwan), Nurses (per 1,000 Population), 2008-2013 225
Figure 79: Healthcare Infrastructure, Republic of China (Taiwan), Pharmacists (per 1,000 Population), 2008-2013 226
Figure 80: Healthcare Infrastructure, Republic of China (Taiwan), Dentists (per 1,000 Population), 2008-2013 227
Figure 81: Healthcare Expenditure, Republic of China (Taiwan), Healthcare Expenditure (% of GDP), 2008-2013 228
Figure 82: Healthcare Expenditure, Republic of China (Taiwan), Primary Healthcare Expenditure, Current Health Expenditure by Provider, Share (%), 2011 229
Figure 83: Healthcare Expenditure, Republic of China (Taiwan), Primary Healthcare Expenditure, Current Health Expenditure by Mode of Production (%), 2011 230
Figure 84: Healthcare Expenditure, Republic of China (Taiwan), Healthcare Expenditure, Public-Private Share (%), 2008-2013 232
Figure 85: Healthcare Expenditure, Republic of China (Taiwan), Pharmaceutical R&D Expenditure ($m), 2008-2013 233
Figure 86: Healthcare Market, Republic of China (Taiwan), Opportunities and Challenges, 2013 238


To order this report: CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Republic of China (Taiwan)
http://www.reportlinker.com/p02154166/CountryFocus-Healthcare-Regulatory-and-Reimbursement-Landscape---Republic-of-China-Taiwan.html



__________________________
Contact Clare: [email protected]
US: (339)-368-6001
Intl: +1 339-368-6001

SOURCE Reportlinker